Clinic Versus Daytime Ambulatory Blood Pressure Difference in Hypertensive Patients: The Impact of Age and Clinic Blood Pressure

Hypertension

Volumn 69, Issue 2, 2017, Pages 211-219

  Banegas, José R ^a   Ruilope, Luis M ^a,b   De La Sierra, Alejandro ^c   Vinyoles, Ernest ^c   Gorostidi, Manuel ^d   De La Cruz, Juan J ^a   Segura, Julián ^b   Oliveras, Anna ^e   Martell, Nieves ^f   García Puig, Juan ^g   Williams, Bryan ^h  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

age group; ambulatory blood pressure monitoring; conventional blood pressure; epidemiology; hypertension

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINIC BLOOD PRESSURE; COMPARATIVE STUDY; CONTROLLED STUDY; DAYTIME AMBULATORY BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; FEMALE; HOSPITAL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MIDDLE AGED; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY; WHITE COAT HYPERTENSION; YOUNG ADULT; ADOLESCENT; BLOOD PRESSURE; CLINICAL TRIAL; MORBIDITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGISTER; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; SPAIN; TRENDS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MORBIDITY; REGISTRIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; YOUNG ADULT;

EID: 85007420328     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.116.08567     Document Type: Article

References (34)

1. Pickering TG, Shimbo D, Haas D, Ambulatory blood-pressure monitoring. N Engl J Med 2006 354 2368 2374. doi: 10.1056/NEJMra060433.
2. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA 1999 282 539 546
3. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, Mancia G, Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005 111 1777 1783. doi: 10.1161/01.CIR.0000160923.04524.5B.
4. Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D, Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997 96 308 315
5. Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A, Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens 1995 13 12 p t 1 1377 1390
6. Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH, Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA 1982 247 992 996
7. Kleinert HD, Harshfield GA, Pickering TG, Devereux RB, Sullivan PA, Marion RM, Mallory WK, Laragh JH, What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension 1984 6 574 578
8. Høegholm A, Kristensen KS, Madsen NH, Svendsen TL, White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Am J Hypertens 1992 5 64 70
9. Thijs L, Amery A, Clement D, Cox J, de Cort P, Fagard R, Fowler G, Guo C, Mancia G, Marin R, Ambulatory blood pressure monitoring in elderly patients with isolated systolic hypertension. J Hypertens 1992 10 693 699
10. Staessen JA, Bieniaszewski L, O'Brien ET, Imai Y, Fagard R, An epidemiological approach to ambulatory blood pressure monitoring:the Belgian Population Study. Blood Press Monit 1996 1 13 26
11. Little P, Barnett J, Barnsley L, Marjoram J, Fitzgerald-Barron A, Mant D, Comparison of agreement between different measures of blood pressure in primary care and daytime ambulatory blood pressure. BMJ 2002 325 254
12. Mancia G, Bertinieri G, Grassi G, Parati G, Pomidossi G, Ferrari A, Gregorini L, Zanchetti A, Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983 2 695 698
13. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH, How common is white coat hypertension? JAMA 1988 259 225 228
14. Ishikawa J, Ishikawa Y, Edmondson D, Pickering TG, Schwartz JE, Age and the difference between awake ambulatory blood pressure and office blood pressure: A meta-Analysis. Blood Press Monit 2011 16 159 167. doi: 10.1097/MBP.0b013e328346d603.
15. Conen D, Aeschbacher S, Thijs L, Age-specific differences between conventional and ambulatory daytime blood pressure values. Hypertension 2014 64 1073 1079. doi: 10.1161/HYPERTENSIONAHA.114.03957.
16. Stergiou GS, Ntineri A, Kollias A, Destounis A, Nasothimiou E, Roussias L, Changing relationship among clinic, home, and ambulatory blood pressure with increasing age. J Am Soc Hypertens 2015 9 544 552. doi: 10.1016/j.jash.2015.04.002.
17. Salice P, Ardissino G, Barbier P, Bacà L, Vecchi DL, Ghiglia S, Colli AM, Galli MA, Marra G, Testa S, Edefonti A, Magrini F, Zanchetti A, Differences between office and ambulatory blood pressures in children and adolescents attending a hospital hypertension clinic. J Hypertens 2013 31 2165 2175. doi: 10.1097/HJH.0b013e3283643361.
18. De la Sierra A, Banegas JR, Segura J, Gorostidi M, Ruilope LM, CARDIORISC Event Investigators Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the Spanish ABPM registry: The CARDIORISC Event study. J Hypertens 2012 30 713 719
19. Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura J, Martell N, García-Puig J, Deanfield J, Williams B, High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J 2014 35 3304 3312. doi: 10.1093/eurheartj/ehu016.
20. O'Brien E, Parati G, Stergiou G, European Society of Hypertension Working Group on Blood Pressure Monitoring European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013 31 1731 1768. doi: 10.1097/HJH.0b013e328363e964.
21. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ, Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005 45 142 161. doi: 10.1161/01.HYP.0000150859.47929.8e.
22. Mancia G, Fagard R, Narkiewicz K, 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013 34 2159 2219. doi: 10.1093/eurheartj/eht151.
23. O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, Imai Y, Wang J, Mengden T, Shennan A, Working Group on Blood Pressure Monitoring of the European Society of Hypertension European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010 15 23 38. doi: 10.1097/MBP.0b013e3283360e98.
24. Artigao LM, Llavador JJ, Puras A, López Abril J, Rubio MM, Torres C, Vidal A, Sanchis C, Divisón JA, Naharro F, Caldevilla D, Fuentes G, [Evaluation and validation of Omron Hem 705 CP and Hem 706/711 monitors for self-measurement of blood pressure]. Aten Primaria 2000 25 96 102
25. Ragazzo F, Saladini F, Palatini P, Validation of the Microlife WatchBP O3 device for clinic, home, and ambulatory blood pressure measurement, according to the International Protocol. Blood Press Monit 2010 15 59 62. doi: 10.1097/MBP.0b013e32833531ca.
26. O'Brien E, Atkins N, Staessen J, State of the market. A review of ambulatory blood pressure monitoring devices. Hypertension 1995 26 835 842
27. O'Brien E, Murphy J, Tyndall A, Atkins N, Mee F, McCarthy G, Staessen J, Cox J, O'Malley K, Twenty-four-hour ambulatory blood pressure in men and women aged 17 to 80 years: The Allied Irish Bank Study. J Hypertens 1991 9 355 360
28. Parati G, Ulian L, Santucciu C, Omboni S, Mancia G, Difference between clinic and daytime blood pressure is not a measure of the white coat effect. Hypertension 1998 31 1185 1189
29. Grassi G, Turri C, Vailati S, Dell'Oro R, Mancia G, Muscle and skin sympathetic nerve traffic during the "white-coat" effect. Circulation 1999 100 222 225
30. Grassi G, Seravalle G, Trevano FQ, Dell'oro R, Bolla G, Cuspidi C, Arenare F, Mancia G, Neurogenic abnormalities in masked hypertension. Hypertension 2007 50 537 542. doi: 10.1161/HYPERTENSIONAHA.107.092528.
31. Tientcheu D, Ayers C, Das SR, McGuire DK, de Lemos JA, Khera A, Kaplan N, Victor R, Vongpatanasin W, Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study. J Am Coll Cardiol 2015 66 2159 2169. doi: 10.1016/j.jacc.2015.09.007.
32. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C, Prognostic significance of the white coat effect. Hypertension 1997 29 1218 1224
33. Messerli FH, Cotiga D, Masked hypertension and white-coat hypertension: Therapeutic navigation between scylla and charybdis. J Am Coll Cardiol 2005 46 516 517. doi: 10.1016/j.jacc.2005.05.001.
34. Palatini P, Penzo M, Canali C, Dorigatti F, Pessina AC, Interactive action of the white-coat effect and the blood pressure levels on cardiovascular complications in hypertension. Am J Med 1997 103 208 216